retatrutide type 2 diabetes trial results 2024 2025 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new phase 3 shows. is part of an emerging generation Retatrutide: A Triple Agonist Shaping

Bezos is an investor in biotech startups Alto Labs and Unity Biotechnology, which research cell rejuvenation and removal of senescent cells, older cells that have stopped dividing but dont die and appear to be a cause of age-associated diseases

Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: a comprehensive review ranging from sulphonylureas to SGLT2 inhibitors

GLP-1 plays a crucial role in regulating blood sugar levels and promoting satiety

Critical commonalities include emphasis on shared decision-making between patients, surgeons, and anaesthetists

For maximum microbiome impact, consider a two-phase approach

Research director Markku Lahteenvuo, from the University of Eastern Finland, said: Because this is a registry-based study, we cannot determine exactly why or how these medications affect mood symptoms, but the association was quite strong